(Updated on: Sep 1, 2021)

Kenji Mizumoto, M.D., MPH, Ph.D.

Associate Professor
Kyoto University, Kyoto, Japan

E-mail: mizumoto.kenji.5a(at)kyoto-u.ac.jp.SPAM
(when you send me an e-mail, please replace (at) by @ and remove ".SPAM").
Researcher profile: Google Scholoar, ORCID, Research Gate,

Message and Research interests

Professional areas:

Area of interest:


Professional Experience (Research)

Under review

  1. Dahal S*, Mizumoto K*, Chowell G.: Investigating spatial variability in COVID-19 pandemic severity across 19 geographic areas, Spain, 2020. medRxiv. 2020.04.14.20065524.preprint.  (doi: )[URL]

Recent publications

  1. Chowell G, Dahal S, Bono R, Mizumoto K*.: Harnessing testing strategies and public health measures to avert COVID-19 outbreaks during ocean cruises. Sci Rep. 2021;11(1):15482. (doi:10.1038/s41598-021-95032-4.)[URL]
  2. Akhmetzhanov AR, Mizumoto K, JungS, Linton NM, Omori R, Nishiura H.: Estimation of the Actual Incidence of Coronavirus Disease (COVID-19) in Emergent Hotspots: The Example of Hokkaido, Japan during February–March 2020. J Clin Med. 2021;10(11),2392. (doi:10.3390/jcm10112392)[URL]
  3. Dahal S, Banda JM, Bento AI,Mizumoto K, Chowell G.: Characterizing all-cause excess mortality patterns during COVID-19 pandemic in Mexico. BMC Infect Dis. 2021;21:432.  (doi:10.1186/s12879-021-06122-7)[URL]
  4. Undurraga EA, Chowell G, Mizumoto K.: Case fatality risk by age from COVID-19 in a high testing setting in Latin America: Chile, March-May, 2020. Infect Dis Poverty. 2021;10(1):11. (doi:10.1186/s40249-020-00785-1)[URL]
  5. Khare S, Dahal S, Luo R, Rothenbeg R, Mizumoto K, Chowell G.: Stillbirth Risk during the 1918 Influenza Pandemic in Arizona, USA. Epidemiologia. 2020;1(1):23-30  (doi:10.3390/epidemiologia1010005)[URL]
  6. Mizumoto K, Kagaya K, Chowell G.: Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City: China, January-February, 2020. BMC Med. 2020;18(1):217. (doi:10.1186/s12916-020-01691-x.)[URL]
  7. Munayco C*, Chowell G*,Tariq A, Undurraga EA, Mizumoto K.: Risk of death by age and gender from CoVID-19 in Peru, March-May, 2020. Aging : Aging (Albany NY) (by Medline/PubMed), Aging-US (by Web of Science). 2020;12:1945-4589. (doi:10.18632/aging.103687)[URL]
  8. Shim E, Mizumoto K, Choi W, Chowell G.: Estimating the risk of COVID-19 death during the course of the outbreak in Korea, February- May, 2020. J Clin Med. 2020; E1641. (doi:10.3390/jcm9061641)[URL]
  9. Oshitani H, the Experts Members of The National COVID-19 Cluster Taskforce at Ministry of Health, Labour and Welfare, Japan.: Cluster-based approach to Coronavirus Disease 2019 (COVID-19) response in Japan—February–April 2020. Jpn J Infect Dis.2020.  (doi:10.7883/yoken.JJID.2020.363.)[URL]
  10. Mizumoto K*, Dahal S*, Chowell G.: Spatial variability in the risk of death from COVID-19 in 20 regions of Italy. Int J Tuberc Lung Dis.2020;24(8)829-837  (doi:10.5588/ijtld.20.0262.)
  11. Mizumoto K, Kagaya K, Chowell G.: Effect of the Wet Market on the coronavirus disease (COVID-19) transmission dynamics in China, 2019-2020. Int J Infect Dis. 2020;97:96-101.  (doi: 10.1016/j.ijid.2020.04.080)[URL]
  12. Omori R, Mizumoto K, Nishiura H.: Ascertainment rate of novel coronavirus disease (COVID-19) in Japan. Int J Infect Dis. 2020;S1201-9712(20)30292-7. (doi: 10.1016/j.ijid.2020.04.080.)[URL]
  13. Omori R, Mizumoto K, Chowell G.: Changes in testing rates could mask the novel coronavirus disease (COVID-19) growth rate. Int J Infect Dis. 2020.pii: S1201-9712(20)30236-8.  (doi:10.1016/j.ijid.2020.04.021)[URL]
  14. Chowell G, Mizumoto K.: The COVID-19 pandemic in the USA: what might we expect? Lancet. 2020;395:1093-1094. Comment. (doi:10.1016/S0140-6736(20)30743-1)[doi]
  15. Mizumoto K, Chowell G: Transmission potential of the novel coronavirus (COVID-19) onboard the diamond Princess Cruises Ship, 2020. Infect Dis Model. 2020;5:264-270. (doi:doi: 10.1016/j.idm.2020.02.003)[doi]
  16. Mizumoto K, Chowell G.: Estimating Risk for Death from 2019 Novel Coronavirus Disease, China, January–February 2020. Emerg Infect Dis. 2020;26(6):1251-1256. (doi:10.3201/eid2606.200233)[doi]
  17. Mizumoto K, Kagaya K, Zarebski A, Chowell G: Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020;25(10). (doi: )[doi]
  18. Mizumoto K, Chowell G.: Temporary fertility decline after a large rubella outbreak, Japan. Emerg Infect Dis. 2020;26(6):1122-1129.  (doi:10.3201/eid2606.181718)[doi]
  19. Mizumoto K, Tariq A, Roosa K, Kong J, Yan P, Chowell G.: Spatial variability in the reproduction number of Ebola virus disease, Democratic Republic of the Congo, January–September 2019. Euro Surveill. 2019;24(42):pii=1900588. (doi: 10.2807/1560-7917.ES.2019.24.42.1900588.)[doi]
  20. Suzuki A, Mizumoto K, Akhmetzhanov AR, Nishiura H.: Interaction Among Influenza Viruses A/H1N1, A/H3N2, and B in Japan. Int J Environ Res Public Health. 2019;16(21). (doi: 10.3390/ijerph16214179.)[doi]
  21. Tariq A, Roosa K, Mizumoto K, Chowell G.: Assessing reporting delays and the effective reproduction number: The 2018-19 Ebola epidemic in DRC, May 2018-January 2019. Epidemics. 2019;26:128-133. (doi: 10.1016/j.epidem.2019.01.003.)[doi]
  22. Chowell G, Mizumoto K, Juan B, Silvestro P, Charles P.: Assessing the potential impact of vector-borne disease transmission following heavy rainfall events: A mathematical framework. Philosophical Transactions B. 2019;374:20180272. (doi:10.1098/rstb.2018.0272.)[doi]
  23. Dahal S, Mizumoto K, Bolin B, Viboud C, Chowell G.: Natality decline and Spatial Variation in Excess Death Rates During the 1918-1920 Influenza Pandemic in Arizona, USA. Am J Epidemiol. 2018;187:2577-2584. (doi:10.1093/aje/kwy146)[doi]
  24. Mizumoto K, Kobayashi T, Chowell G: Transmission potential of modified measles during an outbreak, Japan, March–May 2018. Euro Surveill. 2018;23(24):pii=1800239. (doi:10.2807/1560-7917.ES.2018.23.24.1800239)[doi]
  25. Dahal S, Jenner M, Dinh L, Mizumoto K, Viboud C, Chowell G: Excess mortality patterns during 1918-1921 influenza pandemic in the state of Arizona,USA. Annals of Epidemiology. 2017;pii:S1047-2797:30682-8. (doi: 10.1016/j.annepidem.2017.12.005)[doi]
  26. Nishiura H, Mizumoto K, Asai Y: Assessing the transmission dynamics of measles in Japan, 2016. Epidemics. 2017;20:67-72. (doi: 10.1016/j.epidem.2017.03.005.)[doi]
  27. Dinh L, Chowell G, Mizumoto K, Nishiura H: Estimating the subcritical transmissibility of the Zika outbreak in the State of Florida, USA, 2016. Theor Biol Med Model. 2016;13:20. (doi: 10.1186/s12976-016-0046-1.)[doi]
  28. Nah K, Mizumoto K, Miyamatsu Y, Yasuda Y, Kinoshita R, Nishiura H: Estimating risks of importation and local transmission of Zika virus infection. PeerJ. 2016;4:e1904. [journal]
  29. Nishiura H, Mizumoto K, Villamil-Gomez WE, Rodriguez-Morales AJ: Preliminary estimation of the basic reproduction number of Zika virus infection during Colombia epidemic, 2015-2016. Travel Med Infect Dis. 2016;14:274-6. (doi: 10.1016/j.tmaid.2016.03.016)[doi]
  30. Nishiura H, Mizumoto K, Rock KS, Yasuda Y, Kinoshita R, Miyamatsu Y: A theoretical estimate of the risk of microcephaly during pregnancy with Zika virus infection. Epidemics. 2016;15:66-70. (doi: 10.1016/j.epidem.2016.03.001.)[doi]
  31. Nishiura H, Kinoshita R, Mizumoto K, Yasuda Y, Nah K: Transmission potential of Zika virus infection in the South Pacific. Int J Infect Dis. 2016;45:95-7. (doi: 10.1016/j.ijid.2016.02.017.)[doi]
  32. Nishiura H, Endo A, Saitoh M, Kinoshita R, Ueno R, Nakaoka S, Miyamatsu Y, Dong Y, Chowell G, Mizumoto K: Identifying determinants of heterogeneous transmission dynamics of the Middle East respiratory syndrome (MERS) outbreak in the Republic of Korea, 2015: a retrospective epidemiological analysis. BMJ Open. 2016;6:e009936. (doi: 10.1136/bmjopen-2015-009936.)[doi]
  33. Nishiura H, Miyamatsu Y, Mizumoto K: Objective Determination of End of MERS Outbreak, South Korea, 2015. Emerg Infect Dis. 2016;22:146-8. Letter (doi: 10.3201/eid2201.151383.)[doi]
  34. Mizumoto K , Endo A, Chowell G, Miyamatsu Y, Saitoh M, Nishiura H: Real-time characterization of risks of death associated with the Middle East respiratory syndrome (MERS) in the Republic of Korea, 2015. BMC Med. 2015;13. (doi: 10.1186/s12916-015-0468-3.)[doi]
  35. Mizumoto K, Saitoh M, Chowell G, Miyamatsu Y, Nishiura H: Estimating the risk of Middle East respiratory syndrome (MERS) death during the course of the outbreak in the Republic of Korea, 2015. Int J Infect Dis. 2015;39. (doi: 10.1016/j.ijid.2015.08.005.)[doi]
  36. Nishiura H, Kinoshita R, Miyamatsu Y,Mizumoto K: Investigating the immunizing effect of the rubella epidemic in Japan, 2012-14.  Int J Infect Dis. 2015;38. (doi: 10.1016/j.ijid.2015.07.006.)[doi]
  37. Mizumoto K, Ejima K, Yamamoto T, Nishiura H: On the risk of severe dengue during secondary infection: A systematic review coupled with mathematical modeling. Journal of Vector Borne Diseases. 2014;51:153-64. [journal]
  38. Nishiura H, Ejima K, Mizumoto K, Nakaoka S, Inaba H, Imoto S, Yamaguchi R, Saito MM: Cost-effective length and timing of school closure during an influenza pandemic depend on the severity. Theor Biol Med Model. 2014;11:5. (doi: 10.1186/1742-4682-11-5.)[doi]
  39. Nishiura H, Ejima K, Mizumoto K: Missing information in animal surveillance of MERS-CoV. Lancet Infectious Diseases.  2014;14:100. Correspondence. (doi: 10.1016/S1473-3099(13)70699-6)[doi]
  40. Nishiura H, Mizumoto K, Ejima K: How to interpret the transmissibility of novel influenza A(H7N9): an analysis of initial epidemiological data of human cases from China. Theoretical Biology and Medical Modelling. 2013;10:30. (doi: 10.1186/1742-4682-10-30)[doi]
  41. Mizumoto K, Ejima K, Yamamoto T, Nishiura H: Vaccination and clinical severity: Is the effectiveness of contact tracing and case isolation hampered by past vaccination? International Journal of Environmental Research and Public Health. 2013;10:816-829. (doi: 10.3390/ijerph10030816)[doi]
  42. Nishiura H, Mizumoto K: Epidemiological determinants of successful vaccine development. International Journal of Medical Sciences. 2013;10:382-384 (doi: 10.7150/ijms.5689)[doi]
  43. Mizumoto K, Yamamoto T, Nishiura H: Age-dependent estimates of the epidemiological impact of pandemic influenza (H1N1-2009) in Japan. Computational and Mathematical Methods in Medicine. 2013;2013:637064. (doi: 10.1155/2013/637064)[doi]
  44. Mizumoto K, Nishiura H, Yamamoto T: Effectiveness of antiviral prophylaxis coupled with contact tracing in reducing the transmission of the influenza A (H1N1-2009): A systematic review. Theoretical Biology and Medical Modelling. 2013;10:4. (doi: 10.1186/1742-4682-10-4)[doi]
  45. Mizumoto K, Yamamoto T, Nishiura H: Contact behaviour of children and parental employment behaviour during school closure against the pandemic influenza A (H1N1-2009) in Japan. The Journal of International Medical Research. 2013;41:716-724. (doi: 10.1177/0300060513478061)[doi]
  46. Nishiura H, Mizumoto K, Ejima K, Zhong Y, Cowling BJ, Omori R: Incubation period as part of the case definition of severe respiratory illness caused by a novel coronavirus. Eurosurveillance. 2012;17:pii=20296. [journal]

Oral/Poster presentation in International Conference:

Oral/Poster presentation in National Conference



Workshop Participation